Clinical Trials
33 trialsSTBETA
University Hospital, Bordeaux
GAGA
Universiteit Antwerpen
RAINBOW
University of California, Los Angeles
Precision Medicine for Neurocutaneous Syndromes in Western China
West China Hospital
Predicting Epileptogenic Tubers in Patients with Tuberous Sclerosis Complex
Beijing Children's Hospital
EPISTOPIDEAL
Imagine Institute
The Effectiveness and Safety of Vagus Nerve Stimulation for TRE
Beijing Children's Hospital
TRAIN
University of California, Los Angeles
Preventing Epilepsy Using Vigabatrin In Infants With Tuberous Sclerosis Complex
University of Alabama at Birmingham
STOP2
Children's Hospital Medical Center, Cincinnati
Studies in Patients With Tuberous Sclerosis Complex
Translational Genomics Research Institute
LAM-CAK
University Hospital, Tours
Characterization of Patients With Tuberous Sclerosis Complex, Lymphangioleiomyomatosis and Angiomyolipoma
InCor Heart Institute
RAPAMYCIN FOR KIDNEY ANGIOMYOLIPOMAS
Dana-Farber Cancer Institute
A Pilot Study To Evaluate The Effects of Everolimus on Brain mTOR Activity and Cortical Hyperexcitability in TSC and FCD
NYU Langone Health
RAPT
Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
Early Biomarkers of Autism in Infants With Tuberous Sclerosis Complex (TSC)
Boston Children's Hospital
Treatment
The University of Texas Health Science Center, Houston
Everolimus for Cancer With TSC1 or TSC2 Mutation
Dana-Farber Cancer Institute
SOS
University of Pennsylvania
Potential EEG Biomarkers and Antiepileptogenic Strategies for Epilepsy in TSC
University of Alabama at Birmingham
Early Behavioral Intervention to Improve Social Communication Function in Infants With Tuberous Sclerosis Complex
University of California, Los Angeles
TSC
Boston Children's Hospital
Tuberous Sclerosis Complex Natural History Study: Renal Manifestations
Children's Hospital Medical Center, Cincinnati
Topical Rapamycin and Calcitriol for Angiofibroma of Tuberous Sclerosis
National Taiwan University Hospital
Everolimus (RAD001) Therapy for Epilepsy in Patients With Tuberous Sclerosis Complex (TSC)
Children's Hospital Medical Center, Cincinnati
Tuberous Sclerosis Complex: Facial Angiofibroma Skin Cream
Le Bonheur Children's Hospital
Doxycycline In Lymphangioleiomyomatosis (LAM)
University of Nottingham
Everolimus (RAD001) Therapy of Giant Cell Astrocytoma in Patients With Tuberous Sclerosis Complex
Children's Hospital Medical Center, Cincinnati
RAD001 Therapy of Angiomyolipomata in Patients With TS Complex and Sporadic LAM
Children's Hospital Medical Center, Cincinnati
Long Term Follow Up for RAD001 Therapy of Angiomyolipomata in Patients With Tuberous Sclerosis (TSC) and Sporadic Lymphangioleiomyomatosis (LAM)
Children's Hospital Medical Center, Cincinnati
Topical Rapamycin Therapy to Alleviate Cutaneous Manifestations of Tuberous Sclerosis Complex (TSC) and Neurofibromatosis I (NF1)
The University of Texas Health Science Center, Houston
Rapamycin Therapy for Patients With Tuberous Sclerosis Complex and Sporadic LAM
Children's Hospital Medical Center, Cincinnati